Hepion PharmaceuticalsHEPA
13F holders, Q1 2025 (March 31)16holders
1famous investor
$0.43avg. 13F price*
At the end of Q1 2025, 16 institutions reported holding Hepion Pharmaceuticals Inc. (HEPA) in their 13F filings. The largest holders were Sabby Management, LLC ($360K), Anson Funds Management LP ($45K) and HRT Financial LP ($7K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Hepion Pharmaceuticals Inc.
- CUSIP
- 426897401
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 16 | $420K |
| Exits | 0 | $0 |
Ownership 16 holders
| Sabby Management, LLC | 1.51% | New | 836,615 | $360K |
| Anson Funds Management LP | 0.01% | New | 105,685 | $45K |
| HRT Financial LP | 0.00% | New | 16,387 | $7K |
| Citadel Advisors | 0.00% | New | 15,581 | $7K |
| BlackRock, Inc. | 0.00% | New | 1,658 | $713 |
| PNC Financial Services Group, Inc. | 0.00% | New | 156 | $67 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 110 | $47 |
| FMR LLC | 0.00% | New | 100 | $43 |
| SBI Securities Co., Ltd. | 0.00% | New | 32 | $14 |
| Morgan Stanley | 0.00% | New | 30 | $13 |
| Group One Trading LLC | 0.00% | New | 4 | $2 |
| Allworth Financial LP | 0.00% | New | 1 | $1 |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 3 | $1 |
| Bank of America Corp. | 0.00% | New | 2 | $0 |
| UBS Group AG | 0.00% | New | 1 | $0 |
| Osaic Holdings, Inc. | 0.00% | New | 2 | $0 |
"% of holder's portfolio" is HEPA's weight in each manager's 13F, not the share of Hepion Pharmaceuticals Inc. the manager owns.